Bio Conference Agenda - EDB Mauritius

Investment Opportunities

Mauritius welcomes investment and embraces business. Globally recognised as a safe, stable and easy environment to conduct business, Mauritius is a great place to invest, work, live and retire, with future ready infrastructure, global connectivity and world class talent.

Discover our Incentives and Schemes

Standard & Poor’s reaffirms the “investment grade” status of Mauritius and Moody’s upgrades the sovereign Scorecard-indicated outcome to Baa1-Baa3

27 Sep 2023

Mauritius spearheads Pan-African Collaboration with the Africa Partnership Conference 2023

02 October

Standard & Poor’s reaffirms the “investment grade” status of Mauritius and Moody’s upgrades the sovereign Scorecard-indicated outcome to Baa1-Baa3

27 Sep 2023

Mauritius spearheads Pan-African Collaboration with the Africa Partnership Conference 2023

02 October

Standard & Poor’s reaffirms the “investment grade” status of Mauritius and Moody’s upgrades the sovereign Scorecard-indicated outcome to Baa1-Baa3

27 Sep 2023

Mauritius spearheads Pan-African Collaboration with the Africa Partnership Conference 2023

02 October

Visit the Residency Portal

Standard & Poor’s reaffirms the “investment grade” status of Mauritius and Moody’s upgrades the sovereign Scorecard-indicated outcome to Baa1-Baa3

27 Sep 2023

Mauritius spearheads Pan-African Collaboration with the Africa Partnership Conference 2023

02 October

AGENDA

Agenda Download

Download

AGENDA

October 18, 2023
08:30 - 09:15	Registration, Morning Coffee, and Refreshments
09:15 - 09:30	Welcome Address by the Chief Executive Officer - Economic Development Board
09:30 - 09:45	Opening Remarks by the Hon. Minister of Health and Wellness
09:45 - 10:00	Convergence of Healthcare, Biotech and Technology by Dr Timothy Rebbeck, Professor of Cancer Prevention at the Harvard TH Chan School of Public Health
10:00 - 10:15	Keynote Address by the Hon Minister of Finance, Economic Planning and Development
10:15 - 10:30	Networking Break
10:30 - 11:30	Panel Discussion 1: The Foundations and Application of Precision Medicine
11:30 - 12:30	Panel Discussion 2: Wellness Concepts and their Integration with Global Healthcare Systems
12:30 - 13:30	Networking Lunch Break
13:30 - 14:30	Panel Discussion 3: New developments in the Healthcare Sector
14:30 - 15:30	Panel Discussion 4: Biopharmaceutical Research and Manufacturing
15:30 - 15:45	Networking Break
15:45 - 16:45	Panel Discussion 5: The Clinical Research Industry the Future of Clinical Trials
16:45 -17:45	Panel Discussion 6: Adapting the Health System to provide Value Based Care
17:45 - 18:00	Closing Remarks: CEO, EDB
18:00 - 19:30	Networking Cocktail

The Foundations and Application of Precision Medicine

Brief

Making use of precision medicine to optimize disease prevention, diagnosis, and treatment decision-making through the assimilation and analysis of multiple types of data including both genotypic and phenotypic measures.

Proposed Panel Discussions

Moderator : Dr Timothy Rebbeck, Dana Farber Cancer Institute

Key advances in:

From Bench to Bedside – Professor Rameen Shakur, Cambridge Heartwear Founder & Chairman and Director of Integrative Genomics Unit, University of Brighton
Genetic Testing as Key to Advancing Precision Medicine – Professor Noam Shomron, Director, Rare Genomics Institute (RGI), Israel and Head, Functional Genomics Laboratory – Tel Aviv University, Medical School
Cell and Gene Therapies for Personalised Cancer Treatment – Mr Viswanath Rao, Chief Financial Officer, Immuneel Therapeutics Pvt, India

Wellness Concepts and their Integration with Global Healthcare Systems

Brief

Harnessing the potential of the burgeoning wellness industry and its complementarity with the global healthcare sector – especially through emphasis on optimizing health rather than disease management.

Proposed Panel Discussions

Moderator : (TBC)

Key advances in:

Integrating Health into Wellness – The Chenot Perspective – Dr George, Gaitanos, Chief Operating and Scientific Officer
The Evolution of the Mental Health Concept and the Therapy Options – Dr Jean Marie Batail, Psychiatrist, Guillaume Régnier Hospital Center, France
The Ayurveda Wellness Concept – Ananda in the Himalayas – Mr Mahesh Natarajan, Chief Operating Officer, Ananda in the Himalayas

New developments in the Healthcare Sector

Brief

New advances in the identification and treatment of diseases and technology adoption in the healthcare sector

Proposed Panel Discussions

Moderator : Dr Davy Ip, Nephrologist, Mauritius

Key advances in:

Neurology & Neuroscience – Dr Pradyumna Oak, Director & Head Neurology, Nanavati Max Super Speciality Hospital
Cardiovascular – Dr Dharmesh Ramlugun, Adult and Pediatric Cardiac Surgeon, Strasbourg University Hospital – France
Use of Technology in Surgery – Dr Stephen Jeffery, Urology & Surgery – Urogynaecology, Netcare Christiaan Barnard Memorial Hospital, South Africa

Biopharmaceutical Research and Manufacturing

Brief

State of the global biopharma industry and the rational for developing African manufacturing competences

Proposed Panel Discussions

Moderator : Professor Rameen Shakur, University of Brighton

Key advances in:

Drug Discovery, Development and Commercialisation – Dr Ram Sasisekharan, Professor of Biological Engineering, Massachusetts Institute of Technology
Private Sector Manufacturing Perspective – Sebastian Müller – Business Development Manager, Vetter Pharma
Plant based Therapeutics – CapeBio Pharms, from start up to scale up – Mrs Belinda Shaw, Executive Chair and Founder, CapeBio Pharms

The Clinical Research Industry the Future of Clinical Trials

Brief

Underlying the complexities of clinical research and opportunities for countries with a diverse population base

Proposed Panel Discussions

Moderator : Archana Bhaw-Luximon, Professor Biomaterials Engineering and Nanomedicine Biomaterials, Drug Delivery and Nanotechnology Unit, University of Mauritius

Key advances in:

Case Study – Mr Joseph W. LaPlume, Corporate Executive Vice President, Corporate Development & Strategy Management, Charles River Laboratories, USA
International perspective on : Bioethics, Site Selection, Regulations and Patient Recruitment – Dr Regis Pignol, Global Group Leader Clinical Pharmacology, Sanofi
Regulatory Considerations for Clinical Studies – Ms Anusha Foy, Partner, Head of Life Sciences Regulatory Solutions Practice, KPMG, UK

Adapting the Health System to provide Value Based Care

Brief

Making use of data to identify social determinants to build predictive, preventive, and personalized value-based care for population groups

Proposed Panel Discussions

Moderator : Dr Peter Svalander, CEO, Abiolabs Mauritius

Key non communicable diseases – causes, prevention and treatment options:

Diabetes (Professor Kamlesh Khunti – Primary Care Diabetes and Vascular Medicine, University of Leicester)
Oncology (Dr Timothy Rebbeck- Professor of Cancer Prevention at the Harvard TH Chan School of Public Health and Professor of Medical Oncology at the Dana-Farber Cancer Institute) and

Addressing fertility and benign gynaecology health concerns:

Women’s Health – Reproductive Science – (Professor Joyce Harper: Head of the Reproductive Science and Society Group, UCL Institute for Women’s Health)

Investment Opportunities

Premium Investor Certificate

One investment destination, Many markets to conquer.

Africa Strategy

Making it easier to obtain residency in Mauritius

PREMIUM VISA

One investment destination, Many markets to conquer.

Africa Strategy

AGENDA

AGENDA

THEMATICS

The Foundations and Application of Precision Medicine

Brief

Proposed Panel Discussions

Moderator : Dr Timothy Rebbeck, Dana Farber Cancer Institute

Key advances in:

Wellness Concepts and their Integration with Global Healthcare Systems

Brief

Proposed Panel Discussions

Moderator : (TBC)

Key advances in:

New developments in the Healthcare Sector

Brief

Proposed Panel Discussions

Moderator : Dr Davy Ip, Nephrologist, Mauritius

Key advances in:

Biopharmaceutical Research and Manufacturing

Brief

Proposed Panel Discussions

Moderator : Professor Rameen Shakur, University of Brighton

Key advances in:

The Clinical Research Industry the Future of Clinical Trials

Brief

Proposed Panel Discussions

Moderator : Archana Bhaw-Luximon, Professor Biomaterials Engineering and Nanomedicine Biomaterials, Drug Delivery and Nanotechnology Unit, University of Mauritius

Key advances in:

Adapting the Health System to provide Value Based Care

Brief

Proposed Panel Discussions

Moderator : Dr Peter Svalander, CEO, Abiolabs Mauritius

Key non communicable diseases – causes, prevention and treatment options:

Addressing fertility and benign gynaecology health concerns: